STAT

The virus hunter: In a bygone era, C.J. Peters learned how to bend the rules

A legendary scientist reflects on why he became so successful: He got out of the office — and away from bosses.

GALVESTON, Texas — Drive a few minutes from the seawall here, where the Gulf of Mexico crashes into this island city, and follow some meandering streets through a subdivision of graceful, low-slung homes. Look for the one with the Mardi Gras doll hanging beside the front door.

There you will find a scientific mind of the first order.

At 77, Clarence James Peters, known as C.J., is getting on, walking with more deliberate steps than in his earlier years. But he can still recount in sharp detail anecdotes from a career in which he flew through mountain passes to perilous landing strips and trudged to remote villages. By the time he returned home, he had stolen from Mother Nature some of the secrets of diseases including Bolivian hemorrhagic fever and Rift Valley fever.

Peters was a virus hunter. That often meant spending time in the field, mostly in Latin America but also in Africa, where the work was interesting and the bosses far away. “If you’re in the shadow of the flagpole from headquarters, you’re in trouble,” he explained. “Because there will be somebody poking into everything you’re doing.”

Virus hunting today is not what it used to be. There is still adventure to be had, with bold scientists seeking to uncover the mysteries of the unseen world and ultimately benefit human health. But things have

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks